Valuation: Phaarmasia Limited

Market Cap 61Cr 64.14L 56.3L 52.92L 48.38L 90.41L 91.08L 6.36Cr 2.46Cr 31Cr 2.41Cr 2.36Cr 101.57Cr P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 52Cr 54.02L 47.41L 44.57L 40.75L 76.14L 76.71L 5.35Cr 2.08Cr 26Cr 2.03Cr 1.98Cr 86Cr EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 week+5.88%
Current month-10.02%
1 month+18.42%
3 months-7.13%
6 months+12.84%
Current year-20.17%
1 week 82.65
Extreme 82.65
90
1 month 76
Extreme 76
104.95
Current year 67
Extreme 67
131.75
1 year 30.01
Extreme 30.01
131.75
3 years 23.51
Extreme 23.51
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Chairman 71 14/10/2010
Director/Board Member 55 09/12/2012
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.88%+125.00%+243.51% 64.27L
-1.51%+1.03%+53.89%+108.13% 1,04300Cr
-0.46%+0.26%+51.75%+67.21% 65TCr
-0.27%+0.74%+18.79%+70.99% 47TCr
-0.25%+0.19%+36.95%+45.54% 35TCr
+0.98%+2.91%+20.59%+27.14% 27TCr
-1.91%+2.42%+10.41%+11.04% 26TCr
-0.83%+8.10%+41.85%+52.46% 22TCr
-1.57%+1.93%+31.59%+101.17% 19TCr
-2.53%-7.47%-32.63%-60.41% 18TCr
Average -0.77%+2.57%+35.82%+66.68% 36.33TCr
Weighted average by Cap. -0.84%+2.19%+35.65%+65.02%

Financials

2025 2026
Net sales 24Cr 25.44L 22.33L 20.99L 19.19L 35.86L 36.12L 2.52Cr 97.73L 12Cr 95.53L 93.44L 40Cr 47Cr 49.28L 43.25L 40.66L 37.17L 69.46L 69.98L 4.88Cr 1.89Cr 24Cr 1.85Cr 1.81Cr 78Cr
Net income -1.59Cr -2L -1L -1L -1L -2L -2L -16.44L -6L -81.03L -6L -6L -2.63Cr 18Cr 18.34L 16.1L 15.14L 13.84L 25.86L 26.05L 1.82Cr 70.48L 8.96Cr 68.89L 67.38L 29Cr
Net Debt -19.37L -20.22T -17.75T -16.68T -15.25T -28.5T -28.71T -2L -77.68T -10L -75.94T -74.27T -32.02L -9.7Cr -10.12L -9L -8L -8L -14.27L -14.38L -1Cr -38.89L -4.94Cr -38.02L -37.18L -16Cr
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
23/26/23 90.00 0.00% 127
22/26/22 ₹90.00 +3.45% 580
21/26/21 ₹87.00 -1.14% 238
18/26/18 ₹88.00 -1.12% 213
17/26/17 ₹89.00 -0.28% 620
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock